Sharechat Logo

While you were sleeping: BusinessWire overnight wrap

Thursday 31st July 2008

Text too small?
Wall Street advanced on Wednesday, as energy shares rallied on a rebound in the price of oil amid an unexpected drop in US inventories and a private report signaled a more robust US jobs market than was expected.

Financial shares also gained after the Federal Reserve extended an emergency lending program and the Securities and Exchange Commission prolonged a ban on a type of short sales.

The Dow Jones industrial average shot up 186.13 points, or 1.63%, to 11,583.69. The Standard & Poor's 500 Index advanced 21.06 points, or 1.67%, to 1,284.26. The Nasdaq Composite Index gained 10.10 points, or 0.44%, to 2,329.72.

The S&P 500 extended its rebound from an almost three-year low on July 15 to 5.7% as nine of 10 industry groups advanced.

The ADP Employer Services report, a precursor to Friday's government non-farm payrolls report, showed U.S. private employers added 9,000 jobs in July after job losses of 77,000 in June. Economists had forecast a drop of 60,000.

Exxon, the biggest US crude producer, advanced 4.3% to $84.38, while Chevron, the No. 2, rallied 5.3% to $87.26.

Wal-Mart, the largest retailer in the world, rose $1.11 to $58.56. Disney, the biggest theme-park operator, climbed 75 cents to $31.67.

Drug Setback

In contrast, Irish drugmaker Elan Corp's US-listed shares plunged 41.8 to $19.63 on the NYSE while US pharmaceutical company Wyeth dropped 11.9 to $39.74 after a drug trial showed the risk of a potentially serious side effect in a new Alzheimer's drug jointly developed by the companies.

Oil surged after the US Energy Information Administration said gasoline inventories fell by 3.5 million barrels compared with forecasts of a 200,000 barrel build, as US gasoline production dropped and imports fell.

US crude settled up $4.58 at $126.77 a barrel after falling to $120.42 on Tuesday, its lowest since May 6. London Brent crude rose $4.39 to settle at $127.10.

Gold futures ended 1.5% lower, erasing some early losses, as a stronger dollar and equity gains prompted selling. Gold for the most-active December contract settled down $14.10 at $912.30 an ounce in New York. The August contract for gold hit a bottom of $893.30.

Dollar Gains

The US dollar extended its recovery of the past 10 days. The New York Board of Trade's US dollar index, which tracks the dollar's performance against a basket of six currencies, rose to its highest since June 24 at 73.538, before ending the session around 73.330.

The euro slipped to $1.5567, recovering from one-month lows at $1.5521 in the wake of poor euro zone sentiment data. Against the Japanese yen, the dollar was little changed at 108.12 yen, after climbing to one-month highs at 108.33, according to Reuters data.

The US government will auction $10 billion in 30-year bonds, the most in two years, and $17 billion in 10-year notes next week.

The 30-year bond's yield rose 2 basis points, or 0.02 percentage point, to 4.65% at 4:18pm in New York, according to BGCantor Market Data. It earlier touched 4.70%, the highest since July 23. The price of the 4.375% security maturing in February 2038 fell 1/4, or $2.50 per $1,000 face amount, to 95 21/32.

The 10-year note's yield was little changed at 4.05%, and the two-year note's yield was 2.63%.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors